Excell Research, Inc.

Futó vizsgálatok

• Toboroz

  A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

  NCT07573176· 3. fázis· Forrás

• Toboroz

  A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  NCT07115329· 2. fázis· Forrás

• Meghívásos bevonás

  Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

  NCT06605105· 3. fázis· Forrás

• Fut, nem toboroz

  An Open-Label Study of Azetukalner in Major Depressive Disorder

  NCT06922110· 3. fázis· Forrás

• Fut, nem toboroz

  A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  NCT06775379· 3. fázis· Forrás

• Toboroz

  Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

  NCT06690398· 3. fázis· Forrás

• Toboroz

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· 3. fázis· Forrás

• Toboroz

  Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  NCT06229210· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Depresszió4 toboroz
• Autizmus spektrumzavar2 toboroz
• Bipoláris zavar1 toboroz
• Skizofrénia1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  A Study of K-645 in the Treatment of Multiple Migraine Attacks

  NCT07116499· 2. fázis· Forrás

• Lezárult

  Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients

  NCT06836063· 2. fázis· Forrás

• Lezárult

  A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

  NCT06848075· 2. fázis· Forrás

• Lezárult

  "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

  NCT06564818· 3. fázis· Forrás

• Lezárult

  A Study to Test Different Doses of BI 1569912 in People With Depression

  NCT06558344· 2. fázis· Forrás

• Lezárult

  Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

  NCT06423781· 2. fázis· Forrás

• Lezárult

  Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

  NCT06419608· 2. fázis· Forrás

• Lezárult

  A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05455684· 3. fázis· Forrás

• Lezárult

  A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

  NCT05145413· 3. fázis· Forrás

• Lezárult

  An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

  NCT04820309· 3. fázis· Forrás